New report provides Rheumatoid Arthritis market insight
Date Published:
Q1 Price:
$6,000 Source:
Med Predict The key issue for MedPredict’s Thought
Leader Panel was switching: How long should anti-TNF therapy be tried? What comes next? And what would challenge anti-TNF therapy for
1st-line usage? Also discussed: developing
commercial issues, new mechanisms, unmet needs. Learn More.
More Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
- Pharmaceuticals: United States Industry Guide
- Generic Benchmarking: Brand Erosion at Patent Expiry
- Key Players in Pharmaceutical Contract Manufacturing: Market developments, outsourcing hotspots and growth strategies
- The Future of Biobanks: Regulation, ethics, investment and the humanization of drug discovery
